Impact of the COVID-19 Pandemic on Treatment of Patients With STEMI
Primary percutaneous coronary intervention procedures for STEMI significantly decreased during the COVID-19 pandemic.
General Cardiology
Increase in Overdose-Related Cardiac Arrests in COVID-19
There was a large national increase in overdose-related cardiac arrests during the initial months of the COVID-19 pandemic.
Ongoing Anticoagulant Use Does Not Avert Severe COVID-19
Direct oral anticoagulant (DOAC) use is not associated with a reduction in the risk for severe COVID-19.
Statin Use in Hospitalized DM Patients With COVID-19 Associated with Lower Mortality
Study authors assess the association between statin therapy and in-hospital mortality in patients with COVID-19 and concomitant diabetes mellitus.
Beta-Blockers for Heart Rate Control in Sepsis-Associated Atrial Fibrillation
Treatment with beta-blockers vs amiodarone, calcium channel blockers, or digoxin was associated with improved heart control at 1, but not 6 hours in patients with sepsis and atrial fibrillation.
QTc Interval Prolongation After Admission for COVID-19
Prolongation of the QTc interval was found to be prevalent after 7 days of hospitalization for COVID-19.
Markers for Mortality in COVID-19 Patients With Atrial Fibrillation
Investigators identified prognostic markers associated with mortality in patients with COVID-19 and concomitant atrial fibrillation or atrial flutter.
Elevated Troponin and Mortality Risk in Patients Hospitalized With COVID-19
Patients who are hospitalized with COVID-19 and have an elevated vs normal troponin levels were found to be at higher risk for death.
Age and Previous Cardiac Surgery Increases Mortality Risk in Infective Endocarditis Surgery
Study authors assessed the association between mortality and age, history of cardiac surgery, and other risk factors in patients undergoing surgery for infective endocarditis.
-
Loading...
-
Loading...
Next post in General Infectious Disease
